Impact BioMedical, Inc. (IBO)

Impact BioMedical will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$3.00 - $5.00

Shares Offered

1,500,000

Deal Size

$6.00M

Impact BioMedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021
Selling, General & Admin	0.33	0.4
Research & Development	1.23	1.08
Other Operating Expenses	1.9	1.71
Operating Expenses	3.45	3.19
Operating Income	-3.45	-3.19
Interest Expense / Income	0.44	0.14
Other Expense / Income	3.98	-0.08
Pretax Income	-7.67	-2.7
Income Tax	-0.62	-1.4
Net Income	-7.26	-1.85
Net Income Common	-7.05	-1.3
Free Cash Flow	-2.52	-2.03
EBITDA	-6.33	-2
Depreciation & Amortization	1.11	1.11
EBIT	-7.44	-3.11

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).